Zhang J - Search Results

1

Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell.

Kalra N, Zhang J, Yu Y, Ho M, Merino M, Cao L, Hassan R. Kalra N, et al. Among authors: zhang j. Int J Cancer. 2012 Nov 1;131(9):2143-52. doi: 10.1002/ijc.27471. Epub 2012 Apr 24. Int J Cancer. 2012. PMID: 22323052 Free PMC article.

2

Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients.

Ho M, Hassan R, Zhang J, Wang QC, Onda M, Bera T, Pastan I. Ho M, et al. Among authors: zhang j. Clin Cancer Res. 2005 May 15;11(10):3814-20. doi: 10.1158/1078-0432.CCR-04-2304. Clin Cancer Res. 2005. PMID: 15897581

3

Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.

Hassan R, Remaley AT, Sampson ML, Zhang J, Cox DD, Pingpank J, Alexander R, Willingham M, Pastan I, Onda M. Hassan R, et al. Among authors: zhang j. Clin Cancer Res. 2006 Jan 15;12(2):447-53. doi: 10.1158/1078-0432.CCR-05-1477. Clin Cancer Res. 2006. PMID: 16428485

4

Anti-mesothelin immunotoxin SS1P in combination with gemcitabine results in increased activity against mesothelin-expressing tumor xenografts.

Hassan R, Broaddus VC, Wilson S, Liewehr DJ, Zhang J. Hassan R, et al. Among authors: zhang j. Clin Cancer Res. 2007 Dec 1;13(23):7166-71. doi: 10.1158/1078-0432.CCR-07-1592. Clin Cancer Res. 2007. PMID: 18056197

5

Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.

Hassan R, Ebel W, Routhier EL, Patel R, Kline JB, Zhang J, Chao Q, Jacob S, Turchin H, Gibbs L, Phillips MD, Mudali S, Iacobuzio-Donahue C, Jaffee EM, Moreno M, Pastan I, Sass PM, Nicolaides NC, Grasso L. Hassan R, et al. Among authors: zhang j. Cancer Immun. 2007 Dec 19;7:20. Cancer Immun. 2007. PMID: 18088084 Free PMC article.

6

A binding domain on mesothelin for CA125/MUC16.

Kaneko O, Gong L, Zhang J, Hansen JK, Hassan R, Lee B, Ho M. Kaneko O, et al. Among authors: zhang j. J Biol Chem. 2009 Feb 6;284(6):3739-49. doi: 10.1074/jbc.M806776200. Epub 2008 Dec 15. J Biol Chem. 2009. PMID: 19075018 Free PMC article.

7

Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin.

Sarnovsky R, Tendler T, Makowski M, Kiley M, Antignani A, Traini R, Zhang J, Hassan R, FitzGerald DJ. Sarnovsky R, et al. Among authors: zhang j. Cancer Immunol Immunother. 2010 May;59(5):737-46. doi: 10.1007/s00262-009-0794-4. Epub 2009 Nov 29. Cancer Immunol Immunother. 2010. PMID: 20091030 Free PMC article.

8

The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy.

Xiang X, Phung Y, Feng M, Nagashima K, Zhang J, Broaddus VC, Hassan R, Fitzgerald D, Ho M. Xiang X, et al. Among authors: zhang j. PLoS One. 2011 Jan 31;6(1):e14640. doi: 10.1371/journal.pone.0014640. PLoS One. 2011. PMID: 21305058 Free PMC article.

9

In vivo imaging of human malignant mesothelioma grown orthotopically in the peritoneal cavity of nude mice.

Feng M, Zhang J, Anver M, Hassan R, Ho M. Feng M, et al. Among authors: zhang j. J Cancer. 2011 Mar 1;2:123-31. doi: 10.7150/jca.2.123. J Cancer. 2011. PMID: 21479131 Free PMC article.

10

Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin shedding.

Zhang Y, Chertov O, Zhang J, Hassan R, Pastan I. Zhang Y, et al. Among authors: zhang j. Cancer Res. 2011 Sep 1;71(17):5915-22. doi: 10.1158/0008-5472.CAN-11-0466. Epub 2011 Jul 20. Cancer Res. 2011. PMID: 21775520 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177,227 results

Search Page

Filters